首页> 外文期刊>Food and Drug Law Journal >Five Year Review of Class I Medical Device Recalls: 2004-2008
【24h】

Five Year Review of Class I Medical Device Recalls: 2004-2008

机译:一类医疗设备召回五年回顾:2004-2008年

获取原文
获取原文并翻译 | 示例
           

摘要

Medical device manufacturers--as are all manufacturers of prescription products--are regulated by a variety of laws codified in Title 21, Chapter 9 of the U.S. Code and implemented by U.S. Food and Drug Administration (FDA). One statutory obligation is to monitor the safety of a prescription product and, based on this review, determine whether a product might have to be recalled. Recalls of medical devices have a widespread impact on all the participants involved. For the companies that manufacture and distribute medical devices, a recall can have an appreciable and sudden impact on its operations, the public image (goodwill), and the value of the company. Medical professionals must also deal with the effect of recalls as they are challenged with health decisions for their patients and choices of treatment. Lastly, patients are also affected by medical device recalls whether the device is implanted or used externally,on a regular basis to monitor or maintain their health.
机译:医疗器械制造商-以及所有处方产品制造商-均受美国法典第9章第21章编纂并由美国食品药品管理局(FDA)实施的各种法律的监管。一项法定义务是监视处方产品的安全性,并基于此审查确定是否必须召回该产品。召回医疗器械对所有参与者都具有广泛的影响。对于制造和分销医疗器械的公司而言,召回会对公司的运营,公众形象(商誉)和公司价值产生重大而突然的影响。医疗专业人员还必须应对召回的后果,因为他们面临着为其患者和治疗选择做出健康决定的挑战。最后,患者还会受到医疗器械召回的影响,无论该器械是定期植入还是在外部使用,以监控或维护其健康状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号